Last $15.26 USD
Change Today +0.36 / 2.42%
Volume 350.6K
DRNA On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Douglas M. Fambrough III, Ph.D.

Co-Founder, Chief Executive Officer, President and Director, Dicerna Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 19 board members in 2 different organizations across 6 different industries.

See Board Relationships
45$1,699,423
As of Fiscal Year 2013

Background*

Dr. Douglas M. Fambrough, III, Ph.D, is the Co-Founder and has been its Chief Executive Officer and President at Dicerna Pharmaceuticals Inc since May 2010. Dr. Fambrough served as a Venture Partner at Oxford Bioscience Partners and focused his investments on innovative life science technology companies. Dr. Fambrough joined the Oxford Bioscience Partners in 1999 as an Associate and became a Principal in 2001. He became a Partner in 2005 and served as its General Partner ...

Read Full Background

Corporate Headquarters*

Building 1
Watertown, Massachusetts 02472

United States

Phone: 617-621-8097
Fax: --

Board Members Memberships*

Former Director and Member of Nominating and Corporate Governance Committee
Former Director and Chairman of Nominating & Corporate Governance Committee
Observer
Former Director
Former Director
Director
2003-N/A
Director and Chairman of Nominating & Corporate Governance Committee
2007-N/A
Former Director
2007-Present
Co-Founder, Chief Executive Officer, President and Director

Education*

Bachelor's Degree
Cornell University
Master's Degree
Cornell University
PhD
University of California Berkeley

Other Affiliations*

Annual Compensation*

Salary$375,000
Total Annual Compensation$375,000

Stock Options*

All Other Compensation$8,875
Exercisable Options35,746
Unexercisable Options248,004
Total Number of Options565,000

Total Compensation*

Total Annual Cash Compensation$547,938
Total Short Term Compensation$375,000
Other Long Term Compensation$8,875
Total Calculated Compensation$1,699,423
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DRNA:US $15.26 USD +0.36

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DICERNA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.